Obesity
From the Journals
‘Alarming’ global rise in NAFLD
Nearly one-third of adults around the world has nonalcoholic fatty liver disease, with cases steadily increasing over the years, and with men more...
From the Journals
No adverse impact of obesity in biologic-treated IBD
Inflammatory bowel disease patients with obesity can be safely started on biologic therapies, suggests an analysis of over 3,000 patients.
From the Journals
More reflux after sleeve gastrectomy vs. gastric bypass at 10 years
Importantly, the cumulative incidence of Barrett’s esophagus was similar after both procedures and markedly lower than reported in previous trials...
Conference Coverage
Low-carb, high-fat diet improves A1c, reduces liver fat
Experts update the latest case numbers for acute hepatitis in children and discuss possible factors that result in the disease.
Latest News
Pemvidutide promising for fatty liver disease
Weight loss and multiple improvements in lipid parameters linked to nonalcoholic fatty liver disease were seen in a phase 1 trial.
Conference Coverage
ESG’s cardiometabolic benefits last 5 years
Bariatric surgery’s benefits have been well documented, but endoscopic sleeve gastroplasty is relatively new, so its outcomes haven’t been as well...
Conference Coverage
A surprise and a mystery: NAFLD in lean patients linked to CVD risk
The link between nonalcoholic fatty liver disease and higher risk of CVD may extend beyond people who are overweight or living with obesity.
From the Journals
NAFLD vs. MAFLD: What’s in a name?
NAFLD may not be the most appropriate name because “nonalcoholic” may overemphasize the absence of alcohol, but is “metabolic associated” any...
From the Journals
Obesity interactions complex in acute pancreatitis
Severity scores based on body mass index alone do not accurately predict disease severity in patients with acute pancreatitis.
Conference Coverage
Endoscopic obesity treatments offer alternatives to surgery
These methods have shown lower efficacy but with fewer adverse effects.